Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Mostaghimi

Showing results (321-330 of 340) with videos related to

Pageof 34
Sort By:
Journal of Drugs in Dermatology : JDD|December 5, 2023
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual MeetingKathryn Lee, Michael J Woodbury, Melissa Peri Zundell, et al.
JAMA Dermatology|June 15, 2022
Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus StudyEric Xia, Jane Han, Adam Faletsky, et al.
The Journal of Clinical Investigation|July 23, 2024
Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsetsPranali N Shah, George A Romar, Artür Manukyan, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flaresJames G Krueger, Mrinal K Sarkar, Mark G Lebwohl, et al.
The Journal of Investigative Dermatology|December 18, 2023
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) GroupKanika Kamal, Eric Xia, Sara J Li, et al.
Archives of Dermatological Research|February 20, 2025
Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosumTayler Tobey, Alex G Ortega-Loayza, Sharon I Choe, et al.
JAMA Dermatology|January 5, 2022
Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the USAndrew Creadore, Sheena Desai, Allireza Alloo, et al.
Cutis|July 31, 2024
Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus StudyMcKenzie Needham, Rita Pichardo, Afsaneh Alavi, et al.
JAMA Dermatology|May 5, 2021
Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal NecrolysisMelissa Hoffman, Peter B Chansky, Arjun R Bashyam, et al.
JAMA Dermatology|March 7, 2019
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10Megan H Noe, Misha Rosenbach, Rebecca A Hubbard, et al.
Pageof 34

Showing results (321-330 of 340) with videos related to

Sort By:
Pageof 34
Journal of Drugs in Dermatology : JDD|December 5, 2023
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual MeetingKathryn Lee, Michael J Woodbury, Melissa Peri Zundell, et al.
JAMA Dermatology|June 15, 2022
Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus StudyEric Xia, Jane Han, Adam Faletsky, et al.
The Journal of Clinical Investigation|July 23, 2024
Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsetsPranali N Shah, George A Romar, Artür Manukyan, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flaresJames G Krueger, Mrinal K Sarkar, Mark G Lebwohl, et al.
The Journal of Investigative Dermatology|December 18, 2023
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) GroupKanika Kamal, Eric Xia, Sara J Li, et al.
Archives of Dermatological Research|February 20, 2025
Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosumTayler Tobey, Alex G Ortega-Loayza, Sharon I Choe, et al.
JAMA Dermatology|January 5, 2022
Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the USAndrew Creadore, Sheena Desai, Allireza Alloo, et al.
Cutis|July 31, 2024
Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus StudyMcKenzie Needham, Rita Pichardo, Afsaneh Alavi, et al.
JAMA Dermatology|May 5, 2021
Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal NecrolysisMelissa Hoffman, Peter B Chansky, Arjun R Bashyam, et al.
JAMA Dermatology|March 7, 2019
Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10Megan H Noe, Misha Rosenbach, Rebecca A Hubbard, et al.
Pageof 34